NM_000153.4(GALC):c.411_413del (p.Lys139del) AND Galactosylceramide beta-galactosidase deficiency
- Germline classification:
- Pathogenic/Likely pathogenic (3 submissions)
- Last evaluated:
- Sep 21, 2023
- Review status:
- Somatic classification
of clinical impact: - None
- Review status:
- Somatic classification
of oncogenicity: - None
- Review status:
- Record status:
- current
- Accession:
- RCV000671072.6
Allele description [Variation Report for NM_000153.4(GALC):c.411_413del (p.Lys139del)]
NM_000153.4(GALC):c.411_413del (p.Lys139del)
Condition(s)
- Name:
- Galactosylceramide beta-galactosidase deficiency
- Synonyms:
- Krabbe leukodystrophy; Globoid cell leukoencephalopathy; Galactocerebrosidase deficiency; See all synonyms [MedGen]
- Identifiers:
- MONDO: MONDO:0009499; MedGen: C0023521; Orphanet: 487; OMIM: 245200
-
protein MAL2 [Homo sapiens]
protein MAL2 [Homo sapiens]gi|16418397|ref|NP_443118.1|Protein
Your browsing activity is empty.
Activity recording is turned off.
See more...Assertion and evidence details
Flagged submissions
Submission Accession | Submitter | Review Status (Assertion method) | Clinical Significance (Last evaluated) | Origin | Method | Citations |
---|---|---|---|---|---|---|
SCV000925626 | Ege University Pediatric Genetics, Ege University | flagged submission Reason: Claim with insufficient supporting evidence Notes: Does not cite a number of articles with case-level data supporting pathogenicity. (ACMG Guidelines, 2015) | Uncertain significance (May 15, 2019) | germline | clinical testing |
Last Updated: Sep 29, 2024